The vOICe vision BCI 🧠🇪🇺Aug 30, 2024
MassDevice: Another 5 brain-computer interface companies you should know https://www.massdevice.com/another-5-bci-companies-to-know/ #BCI #NeuroTech from #CorTec, #Neurosoft Bioelectronics, #Paradromics, #Science (with former #Pixium Vision), #Zander Labs
Another 5 brain-computer interface companies you should know

Over the past several months, there have been a number of significant developments in the brain-computer interface (BCI) space.

MassDevice
The vOICe vision BCI 🧠🇪🇺May 21, 2024

Bionic eye gets a new lease of life https://spectrum.ieee.org/pixium-bionic-eye-tech-rescued by @meharris; Ex-#Neuralink exec Max Hodak's new company rescues #Pixium technology; "It's very important to us to avoid another debacle like Argus II."

"Hodak says that Science will hire the majority of Pixium’s 35 engineering and regulatory staff, in a push to get the technology approved in Europe as quickly as possible." (CE mark for medical devices.)

#RetinalImplant #BCI #NeuroTech #blind #blindness

Bionic Eye Gets a New Lease of Life

<p>Ex-Neuralink exec Max Hodak's new company rescues Pixium technology</p>

IEEE Spectrum
The vOICe vision BCI 🧠🇪🇺Apr 25, 2024

Welcoming Pixium Vision's PRIMA retinal prosthesis to Science https://science.xyz/news/pixium-vision-acquisition/ #Science has agreed to acquire assets from #Pixium #Vision SA, including three ongoing clinical trials in late-stage macular degeneration; retinal implant, #AMD

"We are pleased to inform you that the Paris Commercial Court approved the sale of the Pixium Vision business to Science Corporation" https://www.pixium-vision.com $ALPIX

Welcoming Pixium Vision’s PRIMA retinal prosthesis to Science

Science has agreed to acquire assets from Pixium Vision SA, including three ongoing clinical trials in late-stage macular degeneration

Science
Show threadThe vOICe vision BCI 🧠🇪🇺Dec 6, 2023
Given the current market situation, the sole takeover offer for #Pixium Vision likely comes from #Vivani Medical subsidiary #Cortigent, and will be rather low because their focus has shifted from retinal implants to brain implants for vision (Orion) with small staff; $VANI $CRGT $ALPIX
The vOICe vision BCI 🧠🇪🇺Nov 7, 2023
Will their #bionic #eyes be obsolete and unsupported too? As another #retinal #implant company goes broke, the tech's future dims https://spectrum.ieee.org/retina-implant-pixium-sa-receivership by @meharris; investors: #Pixium #Vision is looking for a buyer to invest some $64 million, soon; $ALPIX #BCI #NeuroTech #blind #blindness #PixiumVision
Will Their Bionic Eyes Be Obsolete and Unsupported Too?

As another retinal implant company goes broke, the tech’s future dims

IEEE Spectrum
Show threadThe vOICe vision BCI 🧠🇪🇺Oct 9, 2023
#Pixium #Vision announces the opening of safeguard proceedings https://www.globenewswire.com/news-release/2023/10/09/2756972/0/en/Pixium-Vision-announces-the-opening-of-safeguard-proceedings.html as it "might not be able to face its financial obligations after the end of November 2023 without the protection of such proceedings"; $ALPIX #PixiumVision #blind #blindness
Pixium Vision announces the opening of safeguard proceedings

Pixium Vision announces the opening of safeguard proceedings   Paris, France, October 9, 2023 â€“ 19:00 (CET) â€“ Pixium Vision SA (Euronext Growth Paris -...

Pixium Vision
The vOICe vision BCI 🧠🇪🇺Jul 4, 2023
#Pixium #Vision now has a cash runway lasting until end of September 2023 https://www.globenewswire.com/en/news-release/2023/06/08/2684407/0/en/Pixium-Vision-announces-receipt-of-1-8-million-from-the-French-Government-as-Research-Tax-Credit.html Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit; $ALPIX #retinal #implant
Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit

Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit €1.8 million research tax credit received on June 7,...

Pixium Vision
The vOICe vision BCI 🧠🇪🇺Jun 6, 2023
(LinkedIn) #Pixium Vision: Why dry #AMD patients suffering from profound vision loss represent an enormous market opportunity for investors
https://www.linkedin.com/pulse/why-dry-amd-patients-suffering-from-profound-vision-loss-brian-burg #blind #blindness
Why dry AMD patients suffering from profound vision loss represent an enormous market opportunity for investors

Almost everybody knows somebody within their family who has dry age-related macular degeneration (AMD). This is a debilitating disease in which sufferers experience a progressive loss of the photoreceptor cells in the macula, a structure in the centre of the retina which processes what you see direc

The vOICe vision BCI 🧠🇪🇺May 2, 2023

#Pixium #Vision — Focusing on reaching the #PRIMAvera milestone https://www.edisongroup.com/research/focusing-on-reaching-the-primavera-milestone/32260/ On Pixium's #cash burn rate: Pixium "expects its funds on hand to last until approximately the end of July" (!); $ALPIX

May #The_vOICe be with you!

#RetinalImplant

Pixium Vision — Focusing on reaching the PRIMAvera milestone

Having completed the required 38 implantations in late 2022, Pixium Vision’s key upcoming clinical milestone is the primary efficacy data, expected in or around year-end 2023, from the PRIMAvera European pivotal study assessing the safety and clinical benefits of the wireless Prima System in patients with geographic atrophy due to age-related macular degeneration (GA-AMD). The company’s FY22 results showed a milder operating loss than expected, coming in at €11.9m, below our €12.5m estimate. Pixium has since taken further steps to curb its cash burn rate, and it now expects its funds on hand (€4.7m gross cash as of 31 March) to last until approximately the end of July, versus its prior guidance of June 2023. It is working actively to raise additional funds and has hired two investment banks to reach potential investors worldwide. We have rolled forward our estimates and given that we expect the company’s focus in 2023 and 2024 will be on preparing the Prima System for EU market approval and launch (which we continue to model in H125), we have pushed back our US commercialisation forecast by one year, to H227. We now obtain a pipeline rNPV valuation of €140.1m (vs €146.3m previously).

Edison Group
The vOICe vision BCI 🧠🇪🇺Apr 26, 2023

(PDF, French) #Pixium #Vision annual report for the financial year 2022 https://www.pixium-vision.com/wp-content/uploads/2023/04/2023_04_25_Pixium_Vision_Rapport_annuel_2022.pdf retinal implant, $ALPIX; CE mark expected in Q4 2024 or Q1 2025.

(video, French) Retrouver sa vision à partir d’une rétine artificielle est un espoir bien réel https://vimeo.com/820803441